Abstract

Biomaterials have emerged as a transformative approach in cancer therapy, enabling targeted delivery of therapeutic agents to tumors with precision. This review highlights the advancements in biomaterial design and engineering that enhance the specificity and efficacy of cancer treatments. Key innovations include stimuli-responsive systems, nanoparticles, and hydrogels that can encapsulate drugs and release them in response to the tumor microenvironment. Additionally, the integration of biomaterials with imaging techniques allows for real-time monitoring of treatment progression and tumor response. We discuss the current challenges and future directions in the field, emphasizing the potential of biomaterials to improve patient outcomes and personalize cancer therapy